◆ 会议时间：2025年4月3-5日
◆ 会议地点：希腊 雅典

◆ 会议简介：

2025年第11届世界黑色素瘤大会暨第21届欧洲皮肤肿瘤学协会(EADO)大会将于2025年4月3-5日在希腊雅典举行，会议由黑素瘤世界学会(MWS)与欧洲皮肤肿瘤学协会(EADO)联合组织。

黑色素瘤世界学会(MWS)是WHO黑色素瘤工作组的继任组织，后者于1985-2005年发起组织了世界黑色素瘤大会。WHO黑色素瘤工作组于2005年解散，MWS是于2013年在汉堡举行的第八届世界黑色素瘤大会上发起，2014年6月在慕尼黑成立，并于2016年1月注册成立。MWS将按照1985年以来的传统，每四年举办一次世界黑色素瘤大会，在世界黑色素瘤大会之间，MWS每年都会组织世界黑色素瘤/皮肤癌中心会议。MWS旨在统一全球黑色素瘤的诊断和治疗策略；MWS将建立一个黑色素瘤知识库(MKD)，其中包含黑色素瘤相关循证医学的所有相关文章，以及这些文章的证据表。MWS旨在为全球的黑色素瘤患者提供获得新的更有效治疗方法的途径；MWS将在国际上协调黑色素瘤的临床研究活动，改善黑色素瘤的临床研究。

欧洲皮肤肿瘤学协会(EADO)是一个独立的非营利组织，致力于促进、协调和改进皮肤癌领域的临床和实验室研究活动，包括一级和二级预防、早期发现、临床诊断、临床与实验研究。EADO由来自欧洲和国际的皮肤科医师、肿瘤学家和临床医生以及对皮肤肿瘤学领域宣感兴趣的基础研究科学家组成；EADO通过制定和传播有关皮肤癌诊断和治疗的质量标准和指南来提供领导；为皮肤癌领域的临床、治疗和实验研究提供指导、协调和组织；支持并组织会议，以展示新的研究成果、交流信息和为其成员提供教育；对各国皮肤癌组织的项目提供协调与支持。

EADO每年组织一届学术大会，EADO大会是一个独特的机会，与会者可以参加由全球公认的黑色素瘤和皮肤癌领域的专家提供的讲座。会议议程涵盖黑色素瘤和皮肤癌的各个方面——从流行病学、诊断和预防到晚期肿瘤治疗试验结果等等，会议将确保与会者在皮肤肿瘤学领域获得卓越的教育和社交体验，预计有约1000名皮肤肿瘤学家、外科医生、放射治疗师、解剖病理学家、研究人员和业界专业人士将出席本次EADO年会。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.

11th World Congress of Melanoma
21st European Association of Dermato-Oncology (EADO) Congress (EADO 2025)

Date:
April 3-5, 2025

Venue:
Megaron Athens International Conference Centre, Athens, Greece

摘要征文投稿：

Abstract Submission Deadline: December 15, 2024 at 6:00pm CET

All those interested in presenting abstracts at the congress are invited to submit their work to the Program Committee for review. Selected abstracts will be chosen for an oral presentation during the free communications sessions or as posters at the poster exhibition.
Please note: The acceptance of an abstract does not include the congress registration. Authors must be registered for the congress until February 14, 2025 in order to present their work.

点此提交摘要>>>Submit Abstract>>>

Patient Privacy / Clinical Photography

Photographs should at all times protect the privacy and identity of the subject. Eyes should be blacked out. The source of the photographs must also be declared if not the property of the presenter. This is to prevent the use of photographic material without permission.

Oral Presentations

Selected abstracts will be chosen for an oral presentation during the free communications sessions.

Poster Presentation

Abstracts selected for posters will be presented as posters at the poster exhibition during the congress.

Instructions for Preparation of the Poster:
The suggested dimension for your poster is DIN A0 (approx. 84 cm wide x 119 cm high), portrait format, in English language. Please allocate the top of the poster for the title and author's names and affiliations as stated in the submitted abstract.

Publication

All accepted abstracts will be published in the digital Book of Abstracts which will be available for download on the congress website and in the European Cancer Journal (ECJ).

Dear Colleagues,

The World Congress of Melanoma has always been a unique forum of exchange between physicians, scientists, nurses and students. It constitutes a lively exchange of clinical experiences, research work and clinical trial output among experts from all continents reflecting the enormous progress in the field of melanoma and skin cancer. The congress also offers a great opportunity for young colleagues to interact with distinguished faculty, discuss with industry partners and communicate with representatives of patient organizations, creating a formidable learning environment. The 11th World Congress of Melanoma & 21st EADO Congress will be no exception to the rich heritage, reputation and influence of the previous World Congresses.

From a scientific perspective, the program of the conference will provide a comprehensive overview of the most recent advances in melanoma and cutaneous oncology. A variety of plenary lectures, interactive symposia, and workshops will cover the field of melanoma as squamous cell carcinoma, merkel cell carcinoma, basal cell carcinoma, actinic keratosis, cutaneous sarcoma, adnexal tumors and cutaneous T- and B-cell lymphomas. The entire spectrum of each disease will be presented including epidemiology, prevention and early detection, diagnostics and staging, surgical and radiotherapy and systemic and intralesional therapies. Certain unique elements will be introduced such as special advocacy sessions with the participation of invited policymakers, public health professionals and patient organizations. A series of “gross and microscopic case” sessions will provide a continuous stream of presentations of interesting cases with a specific teaching point presented by residents and younger colleagues. “Socratic dialogues” will also take place in small groups comprised of selected young colleagues from different countries who will be mentored by world-famous experts. Aspired by examples from ancient Greek heritage, the 11th World Congress of Melanoma & 21st EADO Congress will focus on young colleagues, not only serving as a platform of exchanging knowledge but also aiming to a deeply influential effect in their career paths.

Most importantly, the conference will be an opportunity to celebrate the therapeutic milestones achieved in the battle against melanoma. Under the auspices of two renown authorities in the field of continuous medical education, the Melanoma World Society (MWS) and the European Association of Dermato-Oncology (EADO), the conference will honor the remarkable collective achievements in the field and, through its proceedings, will define the work ahead to the ultimate goal of melanoma cure.

The unique surroundings of the cultural city of Athens and the springtime environment will contribute to what we expect will be a landmark event.

Looking forward to welcoming you in Athens 2025!

Alexander J. Stratigos, Athens, Greece
Local Congress President

注册费：

* The resident / student registration rate will be granted only after receipt of proof. The written proof of status /e.g. letter signed by the head of department confirming the status of the applicant / copy of student ID Card) can be uploaded online during the registration process.
** Virtual participation and the on-demand service are not included in the day tickets.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。